Good morning :)
Place Order
Add to Watchlist

Themis Medicare Ltd

THEMISMED

Themis Medicare Ltd

THEMISMED
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,436 cr, stock is ranked 1,052
High RiskStock is 3.28x as volatile as Nifty
264.701.20% (+3.15)
264.701.20% (+3.15)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,436 cr, stock is ranked 1,052
High RiskStock is 3.28x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,436 cr, stock is ranked 1,052
High RiskStock is 3.28x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
45.986.450.19%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Themis Medicare Limited is engaged in manufacturing pharmaceuticals and medicinal chemicals, such as formulations and active pharmaceutical ingredients.

Investor Presentation

View older 

Oct 25, 2024

PDF
View Older Presentations

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 16.52%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.09% to 0.11%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue235.63220.73215.11188.69213.96243.77412.49379.44405.32443.44
Raw Materialssubtract87.3874.5373.1568.8166.6779.48145.08126.16138.28356.67
Power & Fuel Costsubtract10.839.778.419.7011.4911.3212.1811.8313.46
Employee Costsubtract36.3040.0044.6545.6944.2839.9951.9766.1582.41
Selling & Administrative Expensessubtract26.8735.5737.2035.2826.3426.9644.7351.0459.01
Operating & Other expensessubtract32.9023.9821.0822.0017.1523.4345.0231.7037.09
Depreciation/Amortizationsubtract11.897.477.427.998.278.559.4810.4912.2511.02
Interest & Other Itemssubtract12.3311.8411.8711.8212.8812.718.779.569.389.64
Taxes & Other Itemssubtract0.851.600.04-1.862.095.6322.3815.619.9213.12
EPS1.921.821.24-1.172.703.897.936.184.735.76
DPS0.180.000.000.000.180.430.500.500.500.50
Payout ratio0.090.000.000.000.060.110.060.080.110.09
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF

Investor Presentation

May 15PDF
Feb 9PDF
Nov 9PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 17PDF
FY 2025

Annual Report Pending

Investor Presentation

Oct 25PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Themis Medicare Ltd55.986.450.19%
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57—

Price Comparison

Compare THEMISMED with any stock or ETF
Compare THEMISMED with any stock or ETF
THEMISMED
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.15%0.00%0.01%0.10%32.74%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.04%0.05%0.01%0.03%0.05%0.10%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 1 Mutual Funds holding Themis Medicare Ltd

Funds (Top 1)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Bandhan BSE Healthcare Index Fund Direct Plan-Growth

Growth
0.0005%0.07%0.07%85/102 (+3)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

THEMISMED has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.19%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.91 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 12, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Jul 12, 2024

Cash Dividend

Ex DateEx DateSep 1, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 1, 2023

Cash Dividend

Ex DateEx DateSep 8, 2022

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Sep 8, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹4.30

Dividend/Share

₹4.30

Ex DateEx Date

Sep 8, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹1.75

Dividend/Share

₹1.75

Ex DateEx Date

Sep 17, 2020

News & Opinions
Earnings
Themis Medicare consolidated net profit rises 26.24% in the September 2024 quarter

Net profit of Themis Medicare rose 26.24% to Rs 14.29 crore in the quarter ended September 2024 as against Rs 11.32 crore during the previous quarter ended September 2023. Sales rose 11.67% to Rs 117.01 crore in the quarter ended September 2024 as against Rs 104.78 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales117.01104.78 12 OPM %14.6411.84 - PBDT20.2517.03 19 PBT17.8013.96 28 NP14.2911.32 26 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Themis Medicare to discuss results

Themis Medicare will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live

Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter

5 months agoBusiness Standard
Earnings
Themis Medicare consolidated net profit rises 35.68% in the June 2024 quarter

Net profit of Themis Medicare rose 35.68% to Rs 24.68 crore in the quarter ended June 2024 as against Rs 18.19 crore during the previous quarter ended June 2023. Sales rose 27.25% to Rs 122.99 crore in the quarter ended June 2024 as against Rs 96.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales122.9996.65 27 OPM %23.7322.49 - PBDT33.7525.54 32 PBT31.3522.52 39 NP24.6818.19 36 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Themis Medicare to hold board meeting

Themis Medicare will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live

Themis Medicare Standalone March 2023 Net Sales at Rs 80.10 crore, up 0.39% Y-o-Y

1 year agoMoneycontrol

Themis Medicare gains on DCGI nod for Remifentanil injection

1 year agoBusiness Standard

Stocks To Watch: Reliance Industries, Advanced Enzyme, NTPC, Themis Medicare

1 year agoBloomberg Quint

Themis Medicare consolidated net profit declines 7.78% in the September 2022 quarter

2 years agoBusiness Standard

Stocks that will see action today (Oct 7)

2 years agoThe Hindu Businessline